◆ Supra returns after two-year hiatus ◆ Deal reopens SSA benchmark issuance, paused since late October ◆ Relative value in focus after end of ECB buying, recent swap moves

London's airport is the third foreign corporate to tap the Swiss market this week

◆ German bank prints popular tier two under new green funding framework ◆ Label a positive ingredient, says rival banker ◆ Funding completed at no concession

Billions fall out of Stellantis's book after tightening by 40bp during bookbuilding

Equinix, Otis and Zimmer take €2.7bn between them

◆ First SSA euro deal sold in nearly two weeks ◆ Rarity, yield and green label lead to 'strong success' ◆ E-supras' curves referenced for pricing

◆ Donald Trump’s threat to ESG finance in the US ◆ Why ‘woke capitalism’ won’t be put to bed ◆ UK auto ABS faces up to compensation crisis

Politicians and corporations could try to ban pension funds and asset managers considering environmental and social issues

Twenty-four states with 60% of US GDP still committed to going green as IRA wins bipartisan support

Guidance released to help banks with quandary of how to deal with biodiversity

Collateral pools are diversified but industry cannot ignore broader implications of more frequent extreme weather

Oil and gas giant's return to Swiss francs achieves competitive pricing

New issue premium estimates ranged from 'minimal' to 35bp

Cox ABG has cut its all-primary IPO by 13% on its last day of bookbuilding, as it calls on "friends and family" for help

The regulator's final determination is meant to provide guidance to the industry for the next five years, instead it is piling on the pain

Sources close to Class A proposal are confident threshold has been reached

For the first time in 17 years, no South African banks are involved in an overseas sovereign trade

Heavily indebted company expects its yields to fall after next month's regulatory milestone

Loans from captive lenders, large banks likely to be most exposed as court says consumers are compensation

Local banks play a vital role for the country in both domestic and international capital markets

How do I navigate blame culture without burning bridges?

In mid-May GlobalCapital convened representatives of three RMBS issuers with different business models and approaches for a wide-ranging discussion about the state of the UK mortgage markets, funding strategies, and much more. Kensington is the most frequent issuer in European RMBS, with a track record stretching back to 1995, and more than £10bn of assets under management, including about £6bn of servicing mandates. LendInvest and Habito are fintech lenders, with LendInvest originating bridging loans and buy-to-let, funded through securitizations (LendInvest has completed two public deals so far), retail bonds, funds, and private capital, including a £500m partnership with JP Morgan. Habito mixes technology-enabled mortgage broking with its own buy-to-let originations, funded through Citi’s securitization shelf, and has recently launched the first long-term (up to 40 years) fixed rate mortgage product in the UK, funded through a partnership with CarVal Investors.

AstraZeneca, the UK drug company, showed the eager demand for merger and acquisition financings this week when it achieved ultra-tight pricing on a $7bn bond issue to fund its acquisition of US biotech firm Alexion Pharmaceuticals.

Kintor Pharmaceutical raised HK$1.17bn ($151m) on Wednesday from a top-up share placement, while a co-founder simultaneously trimmed his stake in the company.